TheProfitWatch

SRZN - Surrozen, Inc. Common

Day 1m 10m 60m PreMarket Market AfterHours Gap
13.1 0.14 (1.07%) 0.0 (0.0%) -0.01 (-0.08%) -0.01 (-0.08%) 0.15 (1.15%) -0.21 (-1.56%) --- 0.15 (1.15%)

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
2.55
Diluted EPS:
2.55
Basic P/E:
5.1922
Diluted P/E:
5.1922
RSI(14) 1m:
48.61
VWAP:
13.22
RVol:

Events

Period Kind Movement Occurred At

Related News